Indo-MIM Limited subsidiaries added revenue but only ₹6.1 crore PAT
Key highlights
- Indo-MIM subsidiaries generated ₹456.3 crore of revenue before eliminations in H1 FY27.
- Indo-MIM subsidiaries produced ₹6.1 crore of PAT before eliminations, versus ₹443.5 crore of standalone PAT.
- Indo-MIM Inc. earned ₹52.2 crore of PAT, while Triax and Phoenix DeVentures II lost ₹18.2 crore and ₹27.1 crore.
- Indo-MIM consolidated revenue rose 11.8% to ₹2,490.6 crore in H1 FY27.
powered by IRIS

Indo-MIM Limited’s subsidiaries generated ₹456.3 crore of revenue and ₹6.1 crore of profit after tax (PAT) before eliminations in H1 FY27, while its standalone entity recorded ₹443.5 crore of PAT. Indo-MIM Inc.’s ₹52.2 crore profit was largely offset by losses at Triax Industries, Phoenix DeVentures II and two other entities.
Know Indo-MIM inside out
Results, valuation, peers and who's buying, in one view.
How did Indo-MIM subsidiaries affect H1 FY27 revenue?
Indo-MIM subsidiaries added ₹456.3 crore of revenue before eliminations in H1 FY27, taking consolidated revenue to ₹2,490.6 crore from standalone revenue of ₹2,073.1 crore. Eliminations and other items reduced the gross subsidiary amount by ₹38.8 crore, leaving a ₹417.5 crore difference between standalone and consolidated revenue.
Gross subsidiary revenue rose by ₹120.9 crore from ₹335.4 crore in H1 FY26, while standalone revenue increased by ₹145.4 crore from ₹1,927.7 crore. Indo-MIM Inc. and Triax together supplied 90% of the ₹456.3 crore gross subsidiary revenue pool in H1 FY27, compared with 88% of ₹335.4 crore a year earlier.
Phoenix DeVentures II was the only named overseas entity with lower revenue, declining by ₹2.0 crore to ₹23.3 crore in H1 FY27. Standalone revenue represented about 83% of consolidated revenue, down from about 87% in H1 FY26, indicating a larger overseas contribution to the revenue bridge.
What did each Indo-MIM subsidiary contribute to PAT?
Indo-MIM subsidiaries produced combined PAT of ₹6.1 crore before eliminations in H1 FY27 because Indo-MIM Inc.’s ₹52.2 crore profit was offset by ₹46.1 crore of losses at four other entities. The presentation states that Indo-MIM Inc. was the only profitable subsidiary during the period.
Phoenix DeVentures II reported the largest subsidiary loss, at ₹27.1 crore, followed by Triax at ₹18.2 crore. Those two US entities had combined losses of ₹45.3 crore, which nearly offset Indo-MIM Inc.’s ₹52.2 crore PAT contribution.
Conway Marsh Garrett recorded a ₹0.7 crore loss and Indo-MIM Arms Components recorded a ₹0.1 crore loss. The presentation does not provide entity-level reasons for these losses, so it does not identify pricing, costs, utilisation or start-up activity as causes.
Got a follow-up? Ask IRIS
Why was Indo-MIM consolidated PAT close to standalone PAT?
Indo-MIM consolidated PAT was ₹455.3 crore in H1 FY27, only ₹11.8 crore above standalone PAT of ₹443.5 crore, because subsidiaries added ₹6.1 crore before eliminations and eliminations and other items added ₹5.7 crore. The company states that standalone PAT represented 97.4% of consolidated PAT.
The PAT mix differed markedly from the revenue mix in the same six-month period. Standalone operations generated about 83% of ₹2,490.6 crore consolidated revenue, yet accounted for 97.4% of ₹455.3 crore consolidated PAT.
Indo-MIM Inc. and Triax together generated ₹409.8 crore of revenue in H1 FY27, but their PAT outcomes differed: Indo-MIM Inc. earned ₹52.2 crore and Triax lost ₹18.2 crore. The presentation provides no prior-year entity PAT bridge, so it does not support a year-on-year comparison of subsidiary profitability.
Which businesses drove Indo-MIM H1 FY27 revenue growth?
Indo-MIM revenue growth in H1 FY27 was led by metal injection moulding (MIM), investment casting and machining, while the Others category fell by ₹179.9 crore. MIM revenue increased by ₹247.8 crore to ₹1,500.1 crore and accounted for 60% of consolidated revenue.
Investment casting revenue rose by ₹126.4 crore to ₹477.2 crore, while machining increased 55.4% to ₹188.2 crore from ₹121.1 crore. Medical Devices declined 7.1% to ₹23.2 crore, whereas Powders grew 25.1% to ₹20.8 crore.
By product group, consumer revenue rose 46.2% to ₹389.5 crore and aerospace revenue increased 31.5% to ₹223.9 crore. Electronics revenue declined 40.5% to ₹268.1 crore from ₹450.9 crore, while automotive, defence and medical product-group revenue reached ₹615.6 crore, ₹493.8 crore and ₹475.3 crore respectively.
Conclusion
Indo-MIM’s H1 FY27 entity bridge shows that overseas subsidiaries expanded the revenue base, contributing ₹456.3 crore before eliminations, but made a limited ₹6.1 crore combined PAT contribution before eliminations. Indo-MIM Inc. supplied ₹52.2 crore of PAT, while losses at Phoenix DeVentures II and Triax largely absorbed that profit, leaving standalone operations responsible for 97.4% of consolidated PAT.
The next disclosed milestone is management’s update after Q3 FY27. Management has set FY27 targets of ₹5,000 crore of revenue and ₹850 crore of bottom line, while stating it expects to do better; its plan includes converting new parts into production, raising productivity and capacity utilisation, and selectively investing in capacity, automation, advanced materials, tooling and additive manufacturing.


